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Abstract In confluent human dermal fibroblasts brought to
quiescence (G0) by serum starvation, the S phase peaked at 24 h
after serum re-addiction and G2/M phase peaked at 36 h. This
was confirmed by titration of h-gas1 mRNA (a marker of G0
phase) and histone H3 (a marker of S phase). Clusterin mRNA
accumulation progressively increased in cells proceeding to
confluence after seeding and to quiescence upon serum starva-
tion, and peaked at around G0, in parallel with h-gas1 mRNA.
At 6 h (roughly G1 phase) clusterin transcript formed a second
peak, followed by a gradual decrease until 36 h. Correspondence
of clusterin protein accumulation to its mRNA occurred solely
with regard to the G0 peak but not to the second one. The
possible meaning of the cell cycle related clusterin gene
expression is discussed.
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1. Introduction
Clusterin is known as a heterodimeric secreted glycoprotein
of about 80 kDa present in most animal tissues and body
£uids. It was originally described as the major rat Sertoli
cell secretory product [1] and as the major glycoprotein in
ram rete testis, endowed of cell-aggregating properties (hence
the name of clusterin) [2]. Subsequently, clusterin gene was
found to be the major up-regulated gene in the rat ventral
prostate undergoing tissue regression after androgen ablation
[3]. Under normal conditions, it is present at very low levels in
this gland because it is solely expressed in the cuboidal (atro-
phic) cells, a minor population of prostate epithelial cells [4,5].
In the same organ, the abundance of clusterin mRNA under-
goes a marked, almost linear, increase with ageing [5,6].
The human counterpart of the clusterin gene is present as a
single copy in the human genome and localizes to chromo-
some 8 (8p21) [7].
Several synonyms/acronyms have been used to name this
gene/protein, because of the di¡erent biological models in
which it appears to play a role. Thus, the name ‘clusterin’
has been proposed in accordance with an international con-
sensus regarding terminology [8]. Ever since, this highly con-
served protein has been found to be involved in many bio-
logical processes, including apoptosis, cell adhesion and cell-
cell interactions, organogenesis, cell di¡erentiation and trans-
formation, membrane lipid remodelling and transport, repro-
duction, complement regulation, oxidative stress, senescence
and many others (reviewed in [8,9]). Di¡erential regulation
of this gene was shown to occur also in many disease states
including renal diseases, atherosclerosis, neurodegenerative
diseases, infertility, myocardial infarction and cancer [9].
Early investigations suggested a direct association of clus-
terin gene expression with programmed cell death [10] ; how-
ever, recent reports indicate that clusterin is up-regulated in
di¡erent cell types surviving death [11^13]. The latter obser-
vation may correlate with the enhanced levels of clusterin
mRNA found in the prostate of the aging rat [5,6] and rat
embryo ¢broblasts undergoing senescence upon T antigen in-
activation [14], suggesting a role for this gene in preventing
cell death.
Very recently, however, it has been reported [15] that, upon
androgen ablation, the di¡erent clusterin species found in the
rat prostate speci¢cally accumulate in the epithelial cells
undergoing apoptosis.
We have shown previously that, in several biological sys-
tems under the action of agents causing either tissue prolifer-
ation or regression, clusterin gene expression undergoes
changes that are synchronous but opposite to those of ODC
(EC 4.1.1.17) [4,16]. Since ODC is a well known cell cycle
dependent gene that peaks in late G1/early S phases [17,18],
we addressed the question of whether in primary cultures of
synchronized human dermal ¢broblasts the expression of clus-
terin gene undergoes cell cycle dependent changes during the
¢rst round of synchronized cell replication.
2. Materials and methods
2.1. Cell cultures and £ow cytometry analysis
1.2U106 dermal ¢broblasts isolated from skin biopsies of healthy
subjects were plated in DMEM supplemented with 10% FCS and
antibiotics in 75 cm2 £asks [19]. To study the proliferative response,
con£uent cultures were ‘serum starved’ for 14 days in DMEM con-
taining 1% FCS and stimulated by addition of fresh medium supple-
mented with 20% FCS. The proliferation stages of the cells at di¡erent
times during cell cycle progression were assessed by two-parameter
£ow cytometry analysis. This was performed after dual staining:
with PI (red £uorescence) for total DNA content, and with anti-
BrdU/FITC (green £uorescence) after BrdU incorporation into the
newly synthesized cellular DNA, for the speci¢c labelling of cells in
S phase. In the latter instance, 10.0 WM BrdU (from Sigma-Aldrich,
Italia S.r.l.) was added to the cultures at the indicated times, followed
by incubation at 37‡C for 30 min; cells were then harvested by tryp-
sinization and washed twice in 1UPBS, and the DNA was denatu-
rated by incubation with 2.0 N HCl/Triton X-100 for 30 min at room
temperature to produce single-strand molecules. After neutralization
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with 0.1 M Na2B4O7 pH 8.5, followed by resuspension in 0.5%
Tween-20 plus 1.0% BSA in 1UPBS, 10 Wl of anti-BrdU/FITC (Cal-
tag Laboratories, Burlingame, CA, USA) per 1U106 cells was added,
and cells were incubated for 30 min at room temperature. After a
further washing in Tween/BSA/PBS, cells were stained for DNA con-
tent with 5.0 Wg/ml of PI and immediately analyzed by £ow cytom-
etry.
2.2. Northern hybridization
Total cellular RNA was extracted from cell cultures grown under
the above conditions, at the time indicated, using RNAfast (Molec-
ular Systems, San Diego, CA, USA). Ten Wg aliquots were electro-
phoresed in a 1% agarose-formaldehyde gel, blotted on Hybond-N
nylon membranes (Amersham, Italia S.r.l) and then hybridized to
the speci¢c SGP-2 (clusterin) or GAPDH cDNA probes, labelled by
random priming 32[P]-dCTP incorporation as previously indicated [6].
The cDNA fragments were excised out by digestion with the appro-
priate restriction enzymes and puri¢ed from agarose gel by using the
Jetquick Gel Extraction Kit (Genomed GmbH, Germany). The h-gas1
cDNA, kindly donated by Dr. G. Del Sal [20], and the histone H3
full-length cDNA, kindly donated by Dr. G. Stein [21], were puri¢ed,
labelled and used as speci¢c probes following the same procedures.
Quantitation of the autoradiograms was then obtained by densitomet-
ric scanning (LKB Ultrascan XL densitometer).
2.3. Western blots
At the times indicated, cells obtained from cell cultures treated as
above were harvested, washed twice with cold PBS and directly lysed
at 100‡C for 10 min in SDS-PAGE loading bu¡er. The total protein
extract, equivalent to 4U105 cells, was then loaded on each lane and
resolved by electrophoresis on 10% polyacrylamide gel. Clusterin im-
munoreactive bands were detected with the BM Chemiluminescence
Blotting Substrate (POD) (Boehringer Mannheim GmbH, Germany)
using polyclonal anti-rat clusterin antibodies (UPSTATE Biotechnol-
ogy, Lake Placid, NY, USA).
3. Results
The experimental model used in the present study was as
previously detailed [18]. At 2 and 3 days after plating, at 14
days after serum starvation (quiescence state, 0 h) and at
various time intervals between 1 h and 48 h following serum
re-addition, the percentages of total cell population in G0/G1,
S and G2/M phases were detected by £ow cytometry after
BrdU incorporation and anti-BrdU/FITC staining. The high-
est percentage of cells in S phase was found 24 h after serum
re-addition, while G2/M phases peaked at 36 h. The timing of
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Fig. 1. Representative Northern blot experiments on total RNA ex-
tracted from cells harvested at the following times: lane 1, 2nd day
after plating; lane 2, 3rd day after plating (cells at con£uence); lane
3, 14 days after serum starvation (quiescence state). From lane 4 to
lane 10: 1 h, 3 h, 6 h, 12 h, 24 h, 36 h and 48 h after serum stimu-
lation, respectively. The speci¢c radioactive probes used for hybrid-
ization and the size of the speci¢c mRNAs detected are indicated.
The ethidium bromide staining of the same RNA specimens, sepa-
rated on agarose gel, is shown for comparison (10 Wg of total RNA
was loaded on each lane).
Fig. 2. a: Histograms showing the time-course of the abundance of
GAPDH mRNA (white bars) in synchronized normal human der-
mal ¢broblasts harvested as in Fig. 1. The speci¢c mRNA radioac-
tive signals were quanti¢ed by densitometric scanning of the autora-
diograms. Y-axis: relative optical density. The amount of total
RNA recovered from the cell cultures is also shown (black bars).
The RNA recovered from the cell cultures was quanti¢ed by ab-
sorbance at 260 nm (Wg of total RNA/106 cells). Both for GAPDH
mRNA abundance and total RNA recovery data were then normal-
ized by setting at 100% the values obtained from cells harvested on
the 2nd day after plating. The data shown are representatives of
four determinations obtained in separate experiments. b: Quantita-
tion of the radioactive bands of histone H3 mRNA (check bars),
clusterin mRNA (black bars) and h-gas1 mRNA (white bars). For
H3, data have been normalized by setting at 100% the value ob-
tained from cells harvested on the 2nd day after plating, while for
h-gas1 and clusterin the values obtained after the induction of the
quiescence state (G0) were used. The data shown are representatives
of four determinations obtained in separate experiments.
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the cell cycle phases was also con¢rmed by assessing, by
Northern hybridization of total RNA, the abundance of the
transcripts coding for h-gas1, a marker of G0 phase [20],
histone H3, a marker of the S phase [21] and GAPDH, a
housekeeping enzyme (Figs. 1 and 2). GAPDH mRNA exhib-
ited a marked decrease at G0, followed by a gradual increase
from 3 h up to 12 h, and remained constant afterwards. This
pattern paralleled that exhibited by total RNA recovered from
cell cultures (Wg/106 cells) under the same conditions, suggest-
ing that changes in GAPDH mRNA accumulation are the
consequence of the expected changes in the general transcrip-
tional activity of the cells (Fig. 2a). Accumulation of the tran-
script coding for histone H3 (Fig. 2b) dropped dramatically in
cells at con£uence (third day after plating), remained unde-
tectable until 12 h after serum re-addition, reached its highest
value at 24 h (S phase) and returned to a very low level at 48
h. The h-gas1 mRNA (Fig. 2b) increased markedly on the
third day after plating, continued to increase during serum
starvation (G0 phase) and up to 1 h after serum re-addition.
It decreased steeply until 6 h, and started again to rise slowly
up to 48 h, when it returned to the level of the third day after
plating as a possible result of the proliferation activity leading
cells again to con£uence.
The pattern of accumulation of clusterin mRNA showed a
marked, progressive increase in cells proceeding to con£uence
and induced to quiescence by serum starvation (from the sec-
ond day after plating to G0, Fig. 2b). One h after serum re-
addition, the level of clusterin mRNA was still high, it de-
creased at 3 h, exhibited a second peak at 6 h and started to
decline gradually at 12 h. At 48 h it was at about the same
level as shown on the third day after plating.
Changes in the amount of the protein during the cell cycle
phases were assessed by immunoblotting. Fig. 3 shows that a
high molecular weight form of clusterin, of about 60 kDa,
that is recognized by the polyclonal anti-rat clusterin antibod-
ies we have used, markedly accumulated in human dermal
¢broblasts at quiescence (G0), together with two minor species
of about 50 and 45 kDa. This is consistent with the peak of
clusterin mRNA detected at G0 phase, but a direct correlation
between the protein levels and the abundance of mRNA (Figs.
2b and 3) could hardly be found at later time intervals. The
correspondence of the major band with a clusterin isoform
was con¢rmed by the fact that it appeared strongly induced
in the prostate of castrated rats (Fig. 3).
4. Discussion
The data presented here, show that clusterin is a cell cycle
related gene in human dermal ¢broblasts, synchronized by
‘serum starvation’.
The enhanced accumulation of clusterin mRNA shown by
the quiescent cells can hardly be a consequence of apoptotic
processes. In fact, when measuring the amount of apoptotic
cells as subdiploid peak by £ow cytometry, the average values
found under our conditions were 0.78% of total cell popula-
tion during the non-synchronous stage (2nd and 3rd day after
plating), 1.30% in the quiescent state, and 0.80% at the sub-
sequent time intervals after serum stimulation.
In cells reaching quiescence, immunoblotting experiments
with anti-rat clusterin antibodies revealed a large increase in
the accumulation of a protein of about 55^60 kDa and the
appearance of two minor bands of about 50 and 45 kDa. The
major band corresponded to one of the forms of rat clusterin
that is induced in the rat prostate by androgen withdraw (Fig.
3). Increased accumulation of these clusterin isoforms
matched with the increase in the abundance of clusterin
mRNA occurring under the same conditions (Fig. 2b). How-
ever, the correspondence between mRNA and protein accu-
mulation ceased after serum re-addition; in fact, the second
peak of mRNA (6^12 h) was not accompanied by correspond-
ent changes in the levels of protein (compare Figs. 2a and 3).
This may ¢nd an explanation either in the possible existence
of post-transcriptional regulatory events that might prevent
immediate translation of clusterin mRNA during speci¢c
phases of the cell cycle, or in the inability of the antiserum
used to recognize speci¢c isoforms of clusterin that might be
produced, during the di¡erent phases of the cell cycle, by
intracellular di¡erential processing [22] and/or di¡erential
splicing of clusterin mRNA [22,23], an issue which is under
current investigation in our laboratory.
Support to the hypothesis that clusterin overexpression may
be one of the factors leading cells to quiescence comes indi-
rectly from our previous data. In the rat ventral prostate
clusterin mRNA is undetectable in the tall columnar cell pop-
ulation, active in cell division or secretory function, compris-
ing the vast majority of epithelial cells, but it is expressed in a
minor population of non-dividing cuboidal cells [4], that are
considered to derive from the atrophy of the columnar ones.
We have shown that the relative number of these cells in-
creases markedly with ageing [5], thus explaining the marked
progressive increase in the abundance of clusterin mRNA that
occurs under the same conditions [6]. However, since no in-
crease in the rate of apoptosis was shown to accompany the
progressively enhanced proportion of cuboidal cells [5], it is
suggested that the latter represent a form of quiescent, long-
surviving cells formed from the columnar ones, through a
process in which clusterin gene relaxation may play a pivotal
role. Pertinent to this may be the recent ¢nding that clusterin
is a senescence induced gene in mammalian cells [14].
On the other hand, human lymphocytes stimulated to pro-
liferation by PHA exhibited a progressive decrease in the level
of clusterin mRNA [16].
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Fig. 3. Western blot analysis of clusterin protein in synchronized
human dermal ¢broblasts harvested as follows: lane 1, 3rd day after
plating (cells at con£uence); lane 2, 14 days after serum starvation
(G0, quiescence state). From lane 3 to lane 10: 3 h, 6 h, 9 h, 12 h,
18 h, 24 h, 36 h and 48 h after serum stimulation, respectively. To-
tal protein content extracted from 4U105 cells was loaded on each
lane and resolved by electrophoresis on 10% polyacrylamide gel.
For comparison, total protein extracts from normal rat ventral pros-
tate (lane 11) and from the ventral prostate of 4 day castrated rats
(lane 12) are also shown. Clusterin immunoreactive bands were de-
tected by chemiluminescence using polyclonal anti-rat SGP-2 anti-
bodies. The data shown are representatives of four determinations
obtained in separate experiments.
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The recent report [15] that the castration induced forms of
the rat prostate clusterin, including a novel species not de-
tected in intact animals, speci¢cally accumulate in the epithe-
lial cells undergoing apoptosis, does not necessarily contradict
this interpretation. It is in fact conceivable that, under the
prevailing conditions regarding levels of trophic factors, hor-
mones or other stimuli (including those that accumulate with
ageing), speci¢c clusterin forms might be produced that may
cause the cells to follow totally di¡erent fates. Apoptotic
doom or induction to quiescence are the pathways suggested
by the available data. The latter alternative might lead to an
atrophic state that could prevent both cell death and patho-
logical proliferation.
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